Table 1 Patients, tumor, and treatment characteristics
Variable | Value |
|---|---|
Age (years) Median (Q1-Q3) | 55 (44-63.5) |
FIGO Stage (n) | |
IB2 | 3 |
IIA | 3 |
IIB | 6 |
IIIA | 1 |
IIIB | 2 |
IIIC1 | 1 |
IIIC2 | 1 |
IVA | 1 |
BMI (kg/m²) Median (Q1-Q3) | 24.4 (21.75–31.61) |
HR-CTV (cc) Median (Q1-Q3) | 27.48 (20.58–34.66) |
Needles | |
Median (Q1-Q3) | |
Needles implanted (n) Needles used during brachytherapy (+) Contribution (%) | 4 (4–6) 3 (2–4) 11.76 (10.34–19.83) |
Total air Kerma (mGy) Median (Q1-Q3) | 3442 (3020–3770) |
Total Treatment time (s) | 470.7 (357.6-695.7) |
SBRT (Dmax, Gy) Median (Q1-Q3) | 10.71 (10.42–11.26) |